Tech Company Financing Transactions

Dermira Funding Round

Dermira, based in Redwood City, secured $42 million in funding from Bay City Capital, Canaan Partners and New Enterprise Associates.

Transaction Overview

Company Name
Announced On
10/20/2011
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series A
Investors

Bay City Capital (Fred Craves)

Canaan Partners (Wende Hutton)

New Enterprise Associates (Jake Nunn)

Proceeds Purpose
Funds will be used to advance the product pipeline, specifically, lemuteporfin, a potent and selective topical photodynamic therapy (PDT) for acne, licensed from QLT Inc., as well as a robust pipeline of novel, topical small molecule therapeutics for sebaceous gland hyperactivity and inflammatory skin diseases.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
275 Middlefield Rd. 150
Redwood City, CA 94025
USA
Email Address
Overview
Dermira is a biotech company focused on developing and commercializing innovative new therapies in dermatology.
Profile
Dermira LinkedIn Company Profile
Social Media
Dermira Company Twitter Account
Company News
Dermira News
Facebook
Dermira on Facebook
YouTube
Dermira on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thomas Wiggans
  Thomas Wiggans LinkedIn Profile  Thomas Wiggans Twitter Account  Thomas Wiggans News  Thomas Wiggans on Facebook
Chief Medical Officer
Eugene Bauer
  Eugene Bauer LinkedIn Profile  Eugene Bauer Twitter Account  Eugene Bauer News  Eugene Bauer on Facebook
Chief Operating Officer
Andrew Guggenhime
  Andrew Guggenhime LinkedIn Profile  Andrew Guggenhime Twitter Account  Andrew Guggenhime News  Andrew Guggenhime on Facebook
VP - Bus. Development
Chris Griffith
  Chris Griffith LinkedIn Profile  Chris Griffith Twitter Account  Chris Griffith News  Chris Griffith on Facebook
VP - Bus. Development
Luis Peña
  Luis Peña LinkedIn Profile  Luis Peña Twitter Account  Luis Peña News  Luis Peña on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/20/2011: MicroPhage venture capital transaction
Next: 10/20/2011: UltraSolar Technology venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We document tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary